Search - tctmd.com

Displaying 61 - 80 of 1200

Sort: Relevancy | Date

Presentation TCT 2020

TCT 408: Prediction of Vessel Rupture Assessed by Optical Coherence Tomography as a Function of Increasing Pressure and Balloon Size in Stent Post-Dilatation for Calcified Coronary Lesions in Ex-Vivo and In-Silico Experimental Model

Presenter: Luis Dallan

October 14, 2020

Presentation TCT 2020

TCT 404: Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Stenoses: Results From the Disrupt CAD III Optical Coherence Tomography Sub-study

Presenter: Richard Shlofmitz

October 14, 2020

Presentation TCT 2020

TCT 413: Evaluation of the DeepIVUS machine learning platform for automatic detection of stent underexpansion

Presenter: David Molony

October 14, 2020

Presentation TCT 2020

TCT 406: Effect of a Prescriptive Optical Coherence Tomography Guided Strategy on Treatment of In-Stent Restenosis– Insights from the LightLab Initiative

Presenter: Kevin Croce

October 14, 2020

Presentation TCT 2020

TCT 313: OCT-Guided Left Main Stem Percutaneous Coronary Interventions: Results of the Multicenter LEMON (Left Main Oct-Guided Interventions) Cohort Study

Presenter: Nicolas Amabile

October 14, 2020

Presentation TCT 2020

TCT 311: Left Main Lesion Assessment: A Comparison of Angiographic and IVUS Findings

Presenter: Fotis Gkargkoulas

October 14, 2020

Presentation TCT 2020

TCT 312: IVUS Predictors for Bail-out Left Circumflex Stenting After an Initial Strategy of Provisional Stenting When Treating Distal Left Main Bifurcation Lesions

Presenter: Xun Hu

October 14, 2020

Presentation TCT 2020

TCT 280: Automatic Characterization of Human Atherosclerotic Plaque Composition From Intravascular Optical Coherence Tomography Using Artificial Intelligence

Presenter: Shengxian Tu

October 14, 2020

Presentation TCT 2020

TCT 281: Clinical Outcomes of Optical Coherence Tomography Detected High Risk Versus Low Risk Coronary Atherosclerotic Lesions in Medically Treated Fractional Flow Reserve Negative Lesions in Diabetes Mellitus Patients. The COMBINE Trial.

Presenter: Elvin Kedhi

October 14, 2020

Presentation TCT 2020

TCT 284: Intravascular Ultrasound Radiofrequency Signal Analysis for Simultaneous Assessment of Functional Significance and Structural Abnormality of Intermediate Coronary Artery Lesions

Presenter: Kuninobu Kashiyama

October 14, 2020

Presentation TCT 2019

TAVR for Aortic Regurgitation: Clinical Device Evaluation Considerations

Presenter: Vinod Thourani

September 27, 2019

Presentation TCT 2019

TAVR for Bicuspid Aortic Stenosis: What Is Known and What Is Not

Presenter: Michael Mack

September 27, 2019

Presentation TCT 2019

Regulatory Considerations for New Valves and Adjunctive Devices

Presenter: Jennifer Bastijanic

September 27, 2019

Presentation TCT 2019

Transcatheter Mitral Valve Repair and Replacement Devices: Reimbursement Considerations

Presenter: Lori Ashby

September 27, 2019

Presentation TCT 2019

Transcatheter Mitral Valve Repair and Replacement Pivotal Trials: Regulatory Considerations

Presenter: Changfu Wu

September 27, 2019

Presentation TCT 2019

Transcatheter Mitral Valve Repair and Replacement Pivotal Trials: Industry Perspectives

Presenter: Ted Feldman

September 27, 2019

Presentation TCT 2019

Pivotal Transcatheter FMR Device Trials: Future Perspectives One Year After COAPT and MITRA-FR

Presenter: Gregg Stone

September 27, 2019

Presentation TCT 2019

Regulatory Considerations for High Bleeding Risk Patients Undergoing PCI

Presenter: Adrian Magee

September 27, 2019

Presentation TCT 2019

Defining High Bleeding Risk: HBR ARC

Presenter: Philip Urban

September 27, 2019

Presentation TCT 2019

Reimbursement Pathways for Shock Devices

Presenter: Lori Ashby

September 27, 2019

Advertisement

TCT 408: Prediction of Vessel Rupture Assessed by Optical Coherence Tomography as a Function of Increasing Pressure and Balloon Size in Stent Post-Dilatation for Calcified Coronary Lesions in Ex-Vivo and In-Silico Experimental Model

TCT 404: Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Stenoses: Results From the Disrupt CAD III Optical Coherence Tomography Sub-study

TCT 413: Evaluation of the DeepIVUS machine learning platform for automatic detection of stent underexpansion

TCT 406: Effect of a Prescriptive Optical Coherence Tomography Guided Strategy on Treatment of In-Stent Restenosis– Insights from the LightLab Initiative

TCT 313: OCT-Guided Left Main Stem Percutaneous Coronary Interventions: Results of the Multicenter LEMON (Left Main Oct-Guided Interventions) Cohort Study

TCT 311: Left Main Lesion Assessment: A Comparison of Angiographic and IVUS Findings

TCT 312: IVUS Predictors for Bail-out Left Circumflex Stenting After an Initial Strategy of Provisional Stenting When Treating Distal Left Main Bifurcation Lesions

TCT 280: Automatic Characterization of Human Atherosclerotic Plaque Composition From Intravascular Optical Coherence Tomography Using Artificial Intelligence

TCT 281: Clinical Outcomes of Optical Coherence Tomography Detected High Risk Versus Low Risk Coronary Atherosclerotic Lesions in Medically Treated Fractional Flow Reserve Negative Lesions in Diabetes Mellitus Patients. The COMBINE Trial.

TCT 284: Intravascular Ultrasound Radiofrequency Signal Analysis for Simultaneous Assessment of Functional Significance and Structural Abnormality of Intermediate Coronary Artery Lesions

TAVR for Aortic Regurgitation: Clinical Device Evaluation Considerations

TAVR for Bicuspid Aortic Stenosis: What Is Known and What Is Not

Regulatory Considerations for New Valves and Adjunctive Devices

Transcatheter Mitral Valve Repair and Replacement Devices: Reimbursement Considerations

Transcatheter Mitral Valve Repair and Replacement Pivotal Trials: Regulatory Considerations

Transcatheter Mitral Valve Repair and Replacement Pivotal Trials: Industry Perspectives

Pivotal Transcatheter FMR Device Trials: Future Perspectives One Year After COAPT and MITRA-FR

Regulatory Considerations for High Bleeding Risk Patients Undergoing PCI

Defining High Bleeding Risk: HBR ARC

Reimbursement Pathways for Shock Devices

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content